A Study to Evaluate the Drug-drug Interactions (DDIs) of GP681 With Rosuvastatin, Digoxin, Itraconazole, Oseltamivir in Chinese Healthy Volunteers
Clinical trial NCT05789342 · COMPLETED
Trial details
- NCT number
- NCT05789342
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-15
- Primary completion
- 2023-09-11
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.